Clinical trial
Phase II Comparator Study of Substitution of Tenofovir or Abacavir Receiving…
NCT00270556 · Gilead Sciences, Industry · Completed
Key facts
| NCT number | NCT00270556 |
|---|---|
| Title | Phase II Comparator Study of Substitution of Tenofovir or Abacavir Receiving Thymidine Analogue as Part of HAART. |
| Official title | Phase II, Open-Label,Randomised, Comparator Study of Substitution w/Tenofovir or Abacavir in HIV-1 Infected Individuals, w/Viral Load Less 50 Copies/mL, Receiving a Thymidine Analogue (Zidovudine or Stavudine) as Part of HAART. |
| Lead sponsor | Gilead Sciences, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | HIV |
| Intervention type | Drug |
| Interventions | tenofovir disoproxil fumarate, Abacavir |
| Enrollment | 100 |
| Start date | Jan 1, 2003 |
| Completion | Oct 1, 2004 |
| First posted | Dec 28, 2005 |
| Last update posted | Apr 10, 2008 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: